Verisk Analytics (VRSK) — Q2 2026 Earnings Preview

Company

Verisk Analytics, Inc.

Ticker

VRSK (Nasdaq)

Reporting Period

Q2 2026 (quarter ending June 30, 2026)

Expected Earnings Date

TBD — expected late July / early August 2026

Prepared Date

July 28, 2026

Last Earnings Date

April 29, 2026 (Q1 2026)

1. Earnings Preview

Key Takeaway: The setup into Q2 2026 is modestly constructive — consensus sits at a reasonable bar with OCC growth expected to remain below the long-term 6–8% target range, but the trajectory is improving and the biggest swing factor is whether transactional revenue (weather-driven property estimating) shows any sequential recovery.

Heading into Q2 2026, Verisk faces a quarter that management explicitly flagged as still below its long-term OCC growth target range, a continuation of the trough dynamic that defined Q1 2026 (4.7% OCC). Consensus estimates Q2 revenue at ~$804M (+5.3% OCC) with adjusted EBITDA of ~$457M — a bar that reflects the known headwinds (weather carryover, tough subscription renewal comps from the strong H1 2025 cycle, and the government contract work stoppage) but also embeds a gradual sequential improvement narrative that management endorsed at both the Bernstein and William Blair conferences in late May/early June. Guidance tone has been stable-to-constructive: management reaffirmed full-year 2026 guidance ($3.19–$3.24B revenue, $7.45–$7.75 adj. EPS) at Q1 earnings and reiterated confidence in the H2 acceleration at subsequent conferences, with subscription growth sustainability and Core Lines Reimagine value realization cited as the primary drivers. Estimate revisions since the Q1 print have been modest and directionally positive, with Q2 revenue consensus up slightly from the post-Q1 baseline, suggesting the street is broadly aligned with management’s gradual improvement narrative rather than pricing in upside. The stock has rallied ~12.8% since the Q1 earnings date (Apr 29) vs. SPGI down ~2.0%, reflecting both the Q1 beat and growing confidence in the H2 re-acceleration story, which means the stock has already priced in a fair amount of the recovery. The key wildcard is transactional revenue: with no major hurricane activity in H1 2026 and continued softness in personal lines auto, any weather-driven upside (or further disappointment) in property estimating volumes could be the single biggest driver of a beat or miss versus the ~−3.6% OCC transactional consensus.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus sets a modest bar for Q2 2026 — OCC growth of ~5.3% is below the long-term 6–8% target, consistent with management’s own guidance that Q2 may still fall short of the range. Subscription OCC growth (~7.2% consensus) is the more important swing factor; transactional revenue remains a drag but is already expected to be negative, so any weather-driven upside would be incremental.

Table 1 — Q2 2026 Current Quarter Snapshot

KPI

Q1 2026 Actual

Q2 2025 Actual (Prior Year)

Q2 2026 Consensus Estimate

YoY Change

FY 2026 Guidance

Consensus vs. Guidance Midpoint

Total Revenue ($M)

$782.6M

$772.6M

$804.5M

+4.1%

$3,190–$3,240M

~+0.2% vs. $3,215M mid

Organic CC Revenue Growth (%)

4.7%

7.9%

5.3%

-260 bps YoY

6–8% LT target

Below LT range

Subscription Revenue ($M)

$657.5M

$637.5M

$674.2M

+5.8%

~84% of revenue

N/A — no $ guidance

Subscription OCC Growth (%)

7.0%

9.3%

7.2%

-210 bps YoY

Sustained ~7%

In line

Transactional Revenue ($M)

$125.2M

$135.2M

$130.1M

-3.8%

N/A — no $ guidance

N/A

Transactional OCC Growth (%)

-6.1%

+1.8%

-3.6%

N/M

Recovery in H2 2026

Below guidance tone

Adj. EBITDA ($M)

$437.5M

$444.8M

$456.9M

+2.7%

$1,790–$1,830M

~+0.2% vs. $1,810M mid

Adj. EBITDA Margin (%)

55.9%

57.6%

~56.8%

-80 bps YoY

56.0–56.5%

Above guidance range

Adj. EPS (Diluted)

$1.82

$1.88

$1.93

+2.7%

$7.45–$7.75

~+0.4% vs. $7.60 mid

Source: Visible Alpha consensus and actuals data. Note: Q2 2026 adj. EBITDA margin derived from consensus revenue and EBITDA estimates. Prior year Q2 2025 margin of 57.6% included a 120 bps FX translation benefit that management flagged will not recur in Q2 2026, making the YoY margin comparison optically tougher.

Table 2 — Beat/Miss History (Last 8 Quarters)

Top KPI #1: Organic Constant Currency (OCC) Revenue Growth (%)

Quarter

Reported

Consensus

Surprise (bps)

Result

Q1 2026

4.7%

3.98%

+72 bps

Beat

Q4 2025

5.2%

4.51%

+69 bps

Beat

Q3 2025

5.5%

6.69%

-119 bps

Miss

Q2 2025

7.9%

7.43%

+47 bps

Beat

Q1 2025

7.9%

7.08%

+82 bps

Beat

Q4 2024

8.6%

8.17%

+43 bps

Beat

Q3 2024

6.8%

6.34%

+46 bps

Beat

Q2 2024

6.0%

6.84%

-84 bps

Miss

Top KPI #2: Adjusted EPS (Diluted, Operating)

Quarter

Reported

Consensus

Surprise (%)

Result

Q1 2026

$1.82

$1.74

+4.6%

Beat

Q4 2025

$1.82

$1.60

+13.8%

Beat

Q3 2025

$1.72

$1.71

+0.6%

Beat

Q2 2025

$1.88

$1.77

+6.2%

Beat

Q1 2025

$1.73

$1.68

+3.0%

Beat

Q4 2024

$1.61

$1.59

+1.3%

Beat

Q3 2024

$1.67

$1.60

+4.4%

Beat

Q2 2024

$1.74

$1.64

+6.1%

Beat

Pattern: VRSK has beaten adjusted EPS consensus in all 8 of the last 8 quarters, with an average beat of ~5%. OCC growth has beaten in 6 of 8 quarters; the two misses (Q2 2024 and Q3 2025) were both driven by transactional revenue weakness. The consistent EPS beat pattern reflects strong operating leverage and buyback tailwinds, while OCC growth is the more volatile and market-moving metric.

Source: Visible Alpha consensus and actuals data.

3. Guidance & Commentary Evolution

Key Takeaway: Full-year 2026 guidance was reaffirmed in full at Q1 2026 earnings (April 29) and has not been revised since. Management tone has been consistently constructive at post-earnings conferences, emphasizing that Q1 was the trough, subscription growth is sustainable, and H2 will show a natural re-acceleration as the three known headwinds (weather carryover, tough renewal comps, government contract) roll off.

Metric

Initial Guidance (Q1 2026 Earnings, Apr 29)

Revised Guidance

Current Consensus

Note

Revenue (FY 2026)

$3.19B – $3.24B

$3.223B

Unchanged; reaffirmed at Q1 earnings. Consensus sits near midpoint.

Adj. EBITDA (FY 2026)

$1.79B – $1.83B

$1.818B

Unchanged; consensus near high end of range.

Adj. EBITDA Margin (FY 2026)

56.0% – 56.5%

~56.4%

Unchanged; consensus implies ~20 bps above midpoint.

Adj. EPS (FY 2026)

$7.45 – $7.75

$7.67

Unchanged; consensus above midpoint, reflecting buyback tailwind from $1.5B ASR.

OCC Revenue Growth (FY 2026)

6–8% LT target; Q2 may still fall below range

~6.1%

Management guided Q2 could still be below LT range; H2 re-acceleration expected.

CapEx (FY 2026)

$260M – $280M

N/A

Unchanged; prioritizing organic investment.

Interest Expense (FY 2026)

$190M – $200M

N/A

Reflects $1.5B ASR funded via $1B senior notes + $500M term loan.

Q2 2026 Margin Note

Prior year Q2 2025 margin included 120 bps FX benefit that will not recur

~56.8% est.

Tough YoY margin comp flagged by management at Q1 earnings.

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates for Q2 2026 and FY 2026 have moved modestly higher since the Q1 2026 earnings print, tracking management’s reaffirmed guidance. The gap between consensus and guidance midpoints is narrow and positive — suggesting the street is aligned with management’s narrative rather than pricing in meaningful upside or downside. The estimate trajectory represents a cushion, not a risk.

KPI (Period)

Estimate ~5 Days Post Q1 Earnings (May 4, 2026)

Current Consensus (Jul 28, 2026)

Estimate Δ (%)

Initial Guidance (Q1 Earnings Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance (%)

Revenue — Q2 2026

$801.7M

$804.5M

+0.3%

No Q2-specific guidance

No Q2-specific guidance

N/A

Revenue — FY 2026

$3,216M

$3,223M

+0.2%

$3,190–$3,240M

$3,190–$3,240M (unchanged)

0%

+0.2% vs. mid

OCC Growth — Q2 2026

5.27%

5.35%

+8 bps

Below LT 6–8% range

Below LT 6–8% range (unchanged)

0%

In line

OCC Growth — FY 2026

6.11%

6.13%

+2 bps

6–8% LT target

6–8% LT target (unchanged)

0%

At low end of range

Adj. EBITDA — Q2 2026

$454.4M

$456.9M

+0.6%

No Q2-specific guidance

No Q2-specific guidance

N/A

Adj. EBITDA — FY 2026

$1,809M

$1,818M

+0.5%

$1,790–$1,830M

$1,790–$1,830M (unchanged)

0%

+0.4% vs. mid

Adj. EPS — Q2 2026

$1.92

$1.93

+0.6%

No Q2-specific guidance

No Q2-specific guidance

N/A

Adj. EPS — FY 2026

$7.65

$7.67

+0.3%

$7.45–$7.75

$7.45–$7.75 (unchanged)

0%

+0.9% vs. mid

Estimates have drifted modestly higher across all KPIs since the Q1 2026 print, with FY 2026 consensus now sitting slightly above guidance midpoints on revenue, EBITDA, and EPS. This reflects the street’s confidence in the H2 re-acceleration narrative and the buyback tailwind from the $1.5B ASR. The lack of any downward revision since Q1 is a positive signal heading into Q2.

Source: Visible Alpha consensus and actuals data.

5. Stock Performance

Key Takeaway: VRSK has significantly outperformed its sector proxy (SPGI) since Q1 2026 earnings, rallying ~12.8% vs. SPGI down ~2.0% — driven by the Q1 beat, guidance reaffirmation, and growing confidence in the H2 re-acceleration. The stock has re-rated higher on improving fundamentals, meaning the bar for Q2 is now higher than it was three months ago.

VRSK vs. SPGI (Sector Proxy) — Indexed to 100 at Q1 2026 Earnings (Apr 29, 2026). Sector ETF: SPGI (S&P Global) used as a financial data/analytics sector proxy given VRSK’s data analytics business model. Source: Stock Price Data.

6. Peer Commentaries — Read-Through

Key Takeaway: Peer commentary from EFX and TRU in Q2 2026 is broadly constructive for VRSK — insurance vertical demand is robust (TRU: 8th straight quarter of double-digit insurance growth), data analytics spending is accelerating, and AI is driving incremental data consumption rather than displacing incumbents. The soft P&C market cycle is not a headwind to data spending; if anything, carriers are leaning into analytics as underwriting discipline becomes more critical.

TransUnion (TRU) — Q2 2026 Earnings (July 28, 2026)

Relevance: TRU serves P&C insurers within its Emerging Verticals segment (~30% of ~$1.3B emerging verticals revenue). Its insurance vertical is a direct read-through on carrier data spending appetite.

TransUnion (TRU) — Baird Global Consumer, Tech & Services Conference (June 2, 2026)

Relevance: CFO Todd Cello provided detailed commentary on the insurance vertical and Q2 2026 trajectory as of mid-May.

TransUnion (TRU) — Bernstein Strategic Decisions Conference (May 27, 2026)

Relevance: CEO Chris Cartwright provided a comprehensive view on the competitive moat of proprietary data in an AI world and Q2 2026 trajectory.

Equifax (EFX) — Q2 2026 Earnings (July 21, 2026)

Relevance: EFX is a data analytics peer serving financial services and insurance. Its Q2 2026 results and commentary on AI, data demand, and the macro environment are relevant read-throughs.

Equifax (EFX) — William Blair Growth Stock Conference (June 3, 2026)

Relevance: EFX CEO Mark Begor and CFO John Gamble provided detailed commentary on AI strategy, data moats, and the Q2 2026 environment.

VRSK Own Conference Commentary — William Blair (June 2) & Bernstein (May 28, 2026)

Relevance: Management’s own post-Q1 conference commentary provides the most direct read-through on Q2 2026 trajectory and strategic positioning.

Peer Read-Through Summary

Theme

Peer Signal

VRSK Implication

Insurance data demand

TRU: 8th straight quarter of double-digit insurance growth; EFX: “increasing and improving growth in insurance”

Positive — carrier data spending is robust and accelerating

AI & data demand

TRU & EFX: AI-enabled customers consume more data; model refresh cycles accelerating

Positive — validates VRSK’s AI monetization thesis

Proprietary data moats

TRU & EFX: Proprietary data is not accessible to public AI; barriers to entry are high

Positive — reinforces VRSK’s competitive positioning

Macro / end-market

EFX: “Stable but muted” outside mortgage; TRU: Healthy volumes through May

Neutral — no macro headwinds for VRSK’s subscription business

Soft P&C market cycle

TRU: Insurance marketing “almost fully recovered”; carriers back to market

Positive — soft market drives underwriting discipline and data demand

Q2 2026 trajectory

TRU: Tracking at/above guidance through May; EFX: Beat Q2 by $5M on revenue

Positive — healthy data demand environment in Q2 2026

7. Material News & Developments

Key Takeaway: The most material development since Q1 2026 earnings is the CIO departure (July 27, 2026), which is a modest negative signal given VRSK’s AI-heavy strategy, though the transition to interim CIO (CTO Jeff Negrete) and the framing as a planned transition mitigates the concern. Operationally, the period has been characterized by positive strategic developments — Synergy Studio launch, MCP connector rollout, and strong conference commentary.

8. Insider Transaction Activity

Key Takeaway: No open-market discretionary buys or sells from executives since Q1 earnings. The CFO’s recurring 10b5-1 sales (400 shares/month) are plan-driven and not a signal. Director activity is limited to routine equity award grants. No unusual insider activity to flag.

Name

Title

Transaction Type

Shares

Transaction Date

Note

Mann, Elizabeth

CFO

10b5-1 Planned Sale

400

Jul 15, 2026

Recurring 10b5-1 plan sale; third consecutive month of identical 400-share sales. Not discretionary.

Mann, Elizabeth

CFO

10b5-1 Planned Sale

400

Jun 15, 2026

Recurring 10b5-1 plan sale; consistent with prior month pattern.

Mann, Elizabeth

CFO

10b5-1 Planned Sale

400

May 15, 2026

Recurring 10b5-1 plan sale; first post-Q1 earnings sale.

Liss, Samuel G.

Director

Open Market Sale (Option Exercise + Sale)

4,671

Jun 5, 2026

Stock option exercise (M) and same-day sale (S) — standard cashless exercise. Not a discretionary open-market sale.

Liss, Samuel G.

Director

Equity Award Grant

167 (Jun 30) / 1,347 (May 19)

Jun 30 & May 19, 2026

Routine director equity compensation grants (code A). Not open-market purchases.

Multiple Directors (7)

Directors

Equity Award Grant

1,347 each (May 19); 146–163 each (Jun 30)

May 19 & Jun 30, 2026

Routine annual director equity compensation grants (code A). Hendrick, Patiath, Perry, Purtill, Soroye, Stevenson, Vaughan. Not open-market purchases.

Hansen, Bruce Edward

Director

Equity Award Grant (10b5-1)

1,347 (May 19); 2,336 (Jun 1)

May 19 & Jun 1, 2026

Equity award grants; Jun 1 transaction is a 10b5-1 plan award (code M). Routine compensation.

Dailey, Jeffrey J.

Director

Equity Award Grant

1,347

May 19, 2026

Routine annual director equity compensation grant (code A).

Summary: All insider activity since Q1 2026 earnings consists of (1) the CFO’s recurring 10b5-1 plan sales of 400 shares/month — a pre-scheduled, non-discretionary program — and (2) routine director equity compensation grants (code A awards) and one cashless option exercise by Director Liss. There are no open-market discretionary buys or sells from any executive or director. The absence of any discretionary selling at elevated stock prices (VRSK up ~12.8% since Q1 earnings) is a mild positive signal — insiders are not using the rally as an exit opportunity.

Source: Insider Transaction Data (SEC Form 4 filings).